Cytokine concentration in aqueous humor of eyes with diabetic macular edema

Retina

Volumn 32, Issue 10, 2012, Pages 2150-2157

  Jonas, Jost B ^a   Jonas, Rahul A ^b   Neumaier, Michael ^c   Findeisen, Peter ^c  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b Dietrich Bonhoeffer Gymnasium Weinheim ^*  (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adhesion molecules; Diabetic retinopathy; Intraocular cytokines; Matrix metalloproteinases; Vascular endothelial growth factor; VEGF

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR BETA; GAMMA INTERFERON; GELATINASE B; GROWTH FACTOR; HUMAN GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON GAMMA INDUCED PROTEIN; INTERLEUKIN 1A2; INTERLEUKIN 1B; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE INDUCED BY INTERFERON GAMMA; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; HUMAN;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CATARACT; CYTOKINES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84871311849     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182576d07     Document Type: Article

References (47)

1. De Jong PT. Age-related macular degeneration. N Engl J Med 2006;355:1474-1485
2. Wong TY, Hyman L. Population-based studies in ophthalmology. Am J Ophthalmol 2008;146:656-663
3. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331: 1480-1487
4. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 1995;92:10457-10461
5. Nonobe NI, Kachi S, Kondo M, et al. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab. Retina 2009;29:579-585
6. Sato T, Kusaka S, Shimojo H, Fujikado T. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 2009;116: 1599-1603.
7. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996;37:1929-1934
8. Matsuoka M, Ogata N, Otsuji T, et al. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 2004;88:809-815
9. Watanabe D, Suzuma K, Matsua S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353:782-792.
10. Katsura Y, Okano T, Matsumo K, et al. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005;28:2252-2254.
11. Jonas JB, Neumaier M. Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy. Clin Experiment Ophthalmol 2007;35:186-187
12. Jonas JB, Neumaier M. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema. Ophthalmic Res 2007;39:139-142
13. Mori K, Gehlbach P, Ando A, et al. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci 2002;43: 2001-2006
14. Cox OT, Simpson DA, Stitt AW, Gardiner TA. Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol Vis 2003;9:665-672
15. Chan WM, Lai TY, Chan KP, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelialderived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina 2008;28: 1308-1313
16. Takeda A, Baffi JZ, Kleinman ME, et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 2009;460:225-230
17. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in exudative age-related macular degeneration. Arch Ophthalmol 2010;128:1281-1286
18. Shen WY, Yu MJ, Barry CJ, et al. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 1998;82:1063-1071
19. Saishin Y, Saishin Y, Takahashi K, et al. The kinase inhibitor PKC412 suppresses epiretinal membrane formation and retinal detachment in mice with proliferative retinopathies. Invest Ophthalmol Vis Sci 2003;44:3656-3662.
20. Yokota T, Ma RC, Park JY, et al. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin- 1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 2003;52:838-845
21. Kociok N, Heppekausen H, Schraermeyer U, et al. The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells. Exp Eye Res 1998;67:237-250
22. Vinores SA, Henderer JD, Mahlow J, et al. Isoforms of platelet- derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res 1995;60:607-619
23. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35: 3649-3663
24. Lau LI, Liu CJ, Wei YH. Increase of 8-hydroxy-2'-deoxyguanosine in aqueous humor of the patients with exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51:5486-5490
25. Funk M, Karl D, Georgopoulos M, et al. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 2009;116:2393-2399
26. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 2009;50:1025-1032.
27. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431
28. Jonas JB, Akkoyun I, Kreissig I, Degenring RF. Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomised study. Br J Ophthalmol 2005;89: 321-326
29. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
30. Jonas JB, Kreissig I, Degenring RF. Secondary chronic openangle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003;121:729-730.
31. Morgan E, Varro R, Sepulveda H, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004;110:252-266.
32. Funk M, Schmidinger G, Maar N, et al. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010;30:1412-1419.
33. Chan A, Duker JS, Ko TH, et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol 2006;124:193-198.
34. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005;243:3-8.
35. Esser P, Bresgen M, Fischbach R, et al. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. Ger J Ophthalmol 1995;4: 269-274
36. Barile GR, Chang SS, Park LS, et al. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 1999;19:219-227.
37. Limb GA, Hickman-Casey J, et al. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1999;40:2453-2457
38. Hernandez C, Burgos R, Canton A, et al. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care 2001;24:516-521
39. Yuuki T, Kanda T, Kimura Y, et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 2001;15:257-259.
40. Adamiec-Mroczek J, Oficjalska-M?ynczak J. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes-role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:1665-1670
41. Nowak M, Wielkoszynski T, Marek B, et al. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clin Exp Med 2008;8:159-164
42. Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 2002;160:501-509
43. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450-1452.
44. Taubman MB, Rollins BJ, Poon M, et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 1992;70:314-325
45. Furukawa Y, Matsumori A, Ohashi N, et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 1999;84:306-314
46. King GL, Suzuma K. Pigment-epithelium-derived factor-a key coordinator of retinal neuronal and vascular functions. N Engl J Med 2000;342:349-351
47. Wang JY, Lu Q, Tao Y, et al. Intraocular expression of thymosin b4 in proliferative diabetic retinopathy. Acta Ophthalmol 2011;89:E396-E403.